Shenzhen Children's Hospital opens the first domestic children's brain-machine interface clinical and translational ward.

Recently, the country's first children's brain-machine interface clinical and translational research ward was officially inaugurated at Shenzhen Children's Hospital. This marks the entry of brain-machine interface technology into the field of children's medical care and potentially opens up new diagnostic and treatment pathways for children with neurological diseases. The head of the Neurology Center at Shenzhen Children's Hospital, Dezhi Cao, explained that for children with refractory epilepsy who do not respond well to traditional treatments, brain-machine interface technology offers a new solution. This technology can accurately record electrical activity around epileptic foci in real-time and deliver precise electrical stimulation to prevent seizures before they occur. This treatment method does not damage the brain's functional areas, and some patients are expected to achieve seizure control. Currently, brain-machine interface technology has been clinically applied in areas such as vagus nerve electrical stimulation, deep brain electrical stimulation, and deep electrode brainwave monitoring. At the same time, the hospital is actively conducting clinical trials of implantable closed-loop brain collection and stimulation systems, aiming to provide new solutions for children with refractory epilepsy who have identifiable epileptic foci but are not candidates for traditional resective surgery.